| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 5e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.25 | 1e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 1e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-05 |